Does MESNA Cause Diffuse large b-cell lymphoma recurrent? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with MESNA (mesna). This represents 0.2% of all adverse event reports for MESNA.
8
Reports of Diffuse large b-cell lymphoma recurrent with MESNA
0.2%
of all MESNA reports
5
Deaths
1
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From MESNA?
Of the 8 reports, 5 (62.5%) resulted in death, 1 (12.5%) required hospitalization.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MESNA. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does MESNA Cause?
Febrile neutropenia (707)
Pyrexia (352)
Off label use (299)
Cystitis haemorrhagic (294)
Disease progression (273)
Neutropenia (238)
Encephalopathy (226)
Vomiting (200)
Death (184)
Pancytopenia (179)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
GEMCITABINE (280)
Which MESNA Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
MESNA vs METAMIZOLE
MESNA vs METARAMINOL
MESNA vs METAXALONE
MESNA vs METFORMIN
MESNA vs METFORMIN\PIOGLITAZONE